1. Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
- Author
-
Strittmatter F, Stieber P, Nagel D, Füllhase C, Walther S, Stief CG, and Waidelich R
- Subjects
Prostate cancer ,tPSA ,cPSA ,ratio f/tPSA ,ratio c/tPSA ,detection of prostate cancer ,benign hyperplasia of the prostate ,Medicine - Abstract
Abstract Objective To evaluate the performance of total PSA (tPSA), the free/total PSA ratio (f/tPSA), complexed PSA (cPSA) and the complexed/total PSA ratio (c/tPSA) in prostate cancer detection. Methods Frozen sera of 442 patients have been analysed for tPSA, free PSA (fPSA) and cPSA. 131 patients had prostate cancer and 311 patients benign prostatic hyperplasia. Results Differences in the distribution of the biomarkers were seen as follows: tPSA, cPSA and c/tPSA were significantly higher in the PC group, and f/tPSA was significantly higher in the BPH group. In the tPSA-range of 0-4 ng/ml none of the biomarkers showed a significant difference in the distribution between both groups. In the tPSA-ranges of 0-10 ng/ml, 2-10 ng/ml, 4-10 ng/ml and Conclusion F/tPSA offers the best ability to distinguish between both groups in lower tPSA-ranges, followed by c/tPSA. CPSA compared to tPSA offers a better ability to discriminate between both groups in all PSA-ranges and could be used as an initial test for PC.
- Published
- 2011
- Full Text
- View/download PDF